ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag bioinformatics genetics genomics cancer pcr

multicolor DNA sequencing gel
Genetic Mutations Can Be Benign or Cancerous—a New Method to Differentiate Between Them Could Lead to Better Treatments
Ryan Layer, The Conversation | May 27, 2022 | 5 min read
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.
Layered visual representation of multiomics
Integrate and Innovate with NGS and Multiomics
The Scientist and Illumina | May 4, 2023 | 6 min read
Researchers across disciplines combine layers of discovery obtained with accessible NGS-based multiomics approaches.
Bio-Rad 
Leveraging Molecular Technologies to Stay on Top of the Scientific Game
The Scientist Staff | Oct 26, 2022 | 5 min read
Joel Pearson discusses how emerging genomic technologies are shaping his cancer research.
Learning Bioinformatics
Esther Landhuis | Jul 1, 2016 | 8 min read
In today’s data-heavy research environment, wet-lab scientists can benefit from new computational skills.
Single Cell Sequencing in a Nutshell
Single Cell Sequencing in a Nutshell
Niki Spahich, PhD | Mar 31, 2023 | 4 min read
By exploring the inner workings of individual cells, rather than averaging bulk populations, researchers identify rare and important cell subtypes.
Techniques for Assessing Genomic Copy Number Variations
Sarah C.P. Williams | Oct 1, 2016 | 8 min read
As the importance of genomic copy number variations for health and disease becomes clearer, researchers are creating new ways to detect these changes in the genome.
obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
The Scientist Staff | Mar 28, 2024
Q&A: Confirming Next-Gen Sequencing Results with Sanger
Tracy Vence | Oct 11, 2016 | 4 min read
Ambry Genetics CEO Aaron Elliott discusses his team’s recent analysis of 20,000 clinical next-generation sequencing panels.
Diagnosing Cancer: A Genomics and Proteomics Approach
Tom Hollon | Sep 21, 2003 | 7 min read
In 1996, Jeff Trent and colleagues published the first paper describing DNA microarrays as tools for pinpointing gene variants underlying various tumor properties.1 Now, as president and scientific director of Translational Genomics Research Institute (TGEN), in Phoenix, Trent is using microarrays to look for gene expression patterns that can be applied to developing diagnostics. The role of microarrays, Trent says, "will be on the discovery side. Testing all 30,000 genes against a diagnosti

Run a Search

ADVERTISEMENT